B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax

Prolymphocytic leukemia (PLL) is a rare disorder, comprising less than 1% of chronic lymphocytic leukemias [1]. T-cell origin is more common, while B-PLL is rarely encountered. It is mostly affecti...